RECRUITING

Transgenerational Metabolic-Immune Biomarkers of Neurological and Neurodevelopmental Disorders

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The study involves up to 5 visits for a fasting blood draw, behavioral assessments, and/or questionnaires. Other samples may be collected when appropriate. This study is currently recruiting. There is no cost for visits or study-related exams.

Official Title

Transgenerational Metabolic-Immune Biomarkers of Neurological and Neurodevelopmental Disorders

Quick Facts

Study Start:2023-12-13
Study Completion:2028-12-31
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT04322734

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:Not specified to 18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Yes
Standard Ages:CHILD, ADULT
Inclusion CriteriaExclusion Criteria
  1. Age 18 years or older
  2. Willing and able to provide informed consent
  3. Able to understand and follow study procedures
  4. Stable medical condition
  1. Pregnancy or breastfeeding
  2. Severe psychiatric disorders
  3. Active substance abuse
  4. Unstable medical conditions
  5. Inability to comply with study requirements

Contacts and Locations

Study Contact

Richard E Frye, MD, PhD
CONTACT
844-ADTFRes
DrFrye@AutismDiscovery.org

Principal Investigator

Richard E Frye, MD, PhD
STUDY_DIRECTOR
Autism Discovery & Treatment Foundation

Study Locations (Sites)

Southwestern Research and Resource Center
Phoenix, Arizona, 85016
United States
State University of New York, Downstate
Brooklyn, New York, 11203
United States

Collaborators and Investigators

Sponsor: Southwest Autism Research & Resource Center

  • Richard E Frye, MD, PhD, STUDY_DIRECTOR, Autism Discovery & Treatment Foundation

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2023-12-13
Study Completion Date2028-12-31

Study Record Updates

Study Start Date2023-12-13
Study Completion Date2028-12-31

Terms related to this study

Additional Relevant MeSH Terms

  • Autism Spectrum Disorder
  • Mitochondrial Pathology
  • Epilepsy
  • Brain Tumor
  • Psychiatric Disorder
  • Mitochondrial Diseases